COLGATE PALMOLIVE CO

CL 10-K · Q4 2025
API behind this page

CL Q4 2025 request

Playground key active
Request URL /api/financials?ticker=CL&year=2025&quarter=4
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q4 2025 Q4 2024 YoY
Revenue 5,230 4,945 +5.8%
Show Business Segments breakouts
Pet Nutrition · Operating Segments 1,196 1,141 +4.8%
Total Oral, Personal and Home Care · Africa/Eurasia 309 268 +15.3%
Total Oral, Personal and Home Care · Asia Pacific 722 725 -0.4%
Total Oral, Personal and Home Care · Europe 734 668 +9.9%
Total Oral, Personal and Home Care · Latin America 1,248 1,106 +12.8%
Total Oral, Personal and Home Care · North America 1,021 1,037 -1.5%
Total Oral, Personal and Home Care · Operating Segments 4,034 3,804 +6.0%
Cost of Revenue 2,084 1,963 +6.2%
Show Business Segments breakouts
Pet Nutrition · Operating Segments 462 465 -0.6%
Total Oral, Personal and Home Care · Africa/Eurasia 126 113 +11.5%
Total Oral, Personal and Home Care · Asia Pacific 271 264 +2.7%
Total Oral, Personal and Home Care · Europe 267 249 +7.2%
Total Oral, Personal and Home Care · Latin America 552 469 +17.7%
Total Oral, Personal and Home Care · North America 411 405 +1.5%
Gross Profit 3,146 2,982 +5.5%
Selling, General & Administrative 2,070 1,896 +9.2%
Show Business Segments breakouts
Pet Nutrition · Operating Segments 437 402 +8.7%
Total Oral, Personal and Home Care · Africa/Eurasia 113 94 +20.2%
Total Oral, Personal and Home Care · Asia Pacific 267 258 +3.5%
Total Oral, Personal and Home Care · Europe 276 254 +8.7%
Total Oral, Personal and Home Care · Latin America 332 305 +8.9%
Total Oral, Personal and Home Care · North America 393 414 -5.1%
Other Operating Income Expense Net 65 23 +182.6%
Operating Income 92 1,063 -91.3%
Show Business Segments breakouts
Pet Nutrition · Operating Segments 286 274 +4.4%
Total Oral, Personal and Home Care · Africa/Eurasia 65 58 +12.1%
Total Oral, Personal and Home Care · Asia Pacific 187 210 -11.0%
Total Oral, Personal and Home Care · Europe 182 156 +16.7%
Total Oral, Personal and Home Care · Latin America 359 339 +5.9%
Total Oral, Personal and Home Care · North America 204 206 -1.0%
Total Oral, Personal and Home Care · Operating Segments 998 969 +3.0%
Show Consolidation Items breakouts
Corporate Non Segment -1,194 -179 -567.0%
Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component -61 20 -405.0%
Interest Expense 64 66 -3.0%
Income Before Taxes 108 993 -89.1%
Income Tax Expense (Benefit) 113 214 -47.2%
Net Income -5 779 -100.6%
Net Income Loss Attributable To Noncontrolling Interest 32 40 -20.0%
Net Income -37 739 -105.0%
EPS (Basic) -0.04 0.91 -104.4%
EPS (Diluted) -0.04 0.9 -104.4%
Comprehensive Income -29 591 -104.9%
Wtd Avg Shares (Basic) -1.3 -1 -30.0%
Wtd Avg Shares (Diluted) -1.7 -1 -70.0%
Net Income Loss Available To Common Stockholders Basic -37 739 -105.0%

Balance Sheet

Balance Sheet
Metric Q4 2025 Q4 2024 YoY
Current Assets
Cash & Cash Equivalents 1,288 1,096 +17.5%
Accounts Receivable 1,675 1,521 +10.1%
Inventory 2,032 1,987 +2.3%
Other Assets Current 714 713 +0.1%
Total Current Assets 5,709 5,317 +7.4%
Marketable Securities (Current) 107 160 -33.1%
Non-Current Assets
Property, Plant & Equipment 4,660 4,422 +5.4%
Goodwill 3,122 3,272 -4.6%
Show Business Segments breakouts
Pet Nutrition 706 482 +46.5%
Total Oral, Personal and Home Care 2,416 2,790 -13.4%
Total Oral, Personal and Home Care · Africa/Eurasia 82 78 +5.1%
Total Oral, Personal and Home Care · Asia Pacific 185 178 +3.9%
Total Oral, Personal and Home Care · Europe 1,430 1,281 +11.6%
Total Oral, Personal and Home Care · Latin America 161 145 +11.0%
Total Oral, Personal and Home Care · North America 558 1,108 -49.6%
Show Reporting Unit breakouts
Filorga Reporting Unit 51 — —
Deferred Tax Assets 205 195 +5.1%
Other Non-Current Assets 1,098 1,084 +1.3%
Total Assets 16,330 16,046 +1.8%
Operating Lease Right-of-Use Assets 531 529 +0.4%
Intangible Assets (Q) — — —
Show Finite Lived Intangible Assets By Major Class breakouts
Other Intangible Assets 129 218 -40.8%
Trademarks 380 590 -35.6%
Other Assets
Intangible Assets Net Excluding Goodwill 1,536 1,756 -12.5%
Show Indefinite Lived Intangible Assets By Major Class breakouts
Unclassified Indefinitelived Intangible Assets 1,027 948 +8.3%
Current Liabilities
Short Term Bank Loans And Notes Payable 1,117 660 +69.2%
Accounts Payable 2,089 1,805 +15.7%
Accrued Income Taxes Current 383 403 -5.0%
Other Accrued Liabilities Current 3,264 2,891 +12.9%
Total Current Liabilities 6,853 5,759 +19.0%
Current Portion of Long-Term Debt 1,115 652 +71.0%
Non-Current Liabilities
Long-Term Debt 6,871 7,289 -5.7%
Deferred Tax Liabilities 181 343 -47.2%
Other Non-Current Liabilities 2,060 2,111 -2.4%
Total Liabilities 15,965 15,502 +3.0%
Long-Term Debt 7,839 — —
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 7,988 7,949 +0.5%
Operating Lease Liabilities 448 456 -1.8%
Stockholders' Equity
Common Stock 1,466 1,466 0.0%
Additional Paid-In Capital 4,322 4,181 +3.4%
Retained Earnings 26,595 26,145 +1.7%
Accumulated Other Comprehensive Income -3,879 -4,222 +8.1%
Treasury Stock Common Value -28,450 -27,358 -4.0%
Total Stockholders' Equity 54 212 -74.5%
Minority Interest 311 332 -6.3%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 365 544 -32.9%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -3,879 -4,222 +8.1%
Additional Paid In Capital 4,322 4,181 +3.4%
Common Stock 1,466 1,466 0.0%
Noncontrolling Interest 311 332 -6.3%
Retained Earnings 26,595 26,145 +1.7%
Treasury Stock Common -28,450 -27,358 -4.0%
Total Liabilities & Equity 16,330 16,046 +1.8%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q4 2025 YTD Q4 2024 YoY
Operating Activities
Depreciation & Amortization 173 148 +16.9%
Show Business Segments breakouts
Pet Nutrition · Operating Segments 46 32 +43.8%
Total Oral, Personal and Home Care · Africa/Eurasia 3 2 +50.0%
Total Oral, Personal and Home Care · Asia Pacific 21 21 0.0%
Total Oral, Personal and Home Care · Europe 18 16 +12.5%
Total Oral, Personal and Home Care · Latin America 28 23 +21.7%
Total Oral, Personal and Home Care · North America 31 31 0.0%
Total Oral, Personal and Home Care · Operating Segments 101 93 +8.6%
Show Consolidation Items breakouts
Corporate Non Segment 26 23 +13.0%
Restructuring Net Of Cash 8 -3 +366.7%
Stock-Based Compensation 28 27 +3.7%
Deferred Income Taxes And Tax Credits -117 21 -657.1%
Increase Decrease In Receivables 164 128 +28.1%
Change in Inventory 100 -6 +1766.7%
Net Cash from Operations 1,453 1,269 +14.5%
Investing Activities
Payments To Acquire Productive Assets -177 -184 +3.8%
Payments To Acquire Marketable Securities -161 -216 +25.5%
Proceeds From Sale And Maturity Of Marketable Securities 244 304 -19.7%
Other Investing Activities -9 16 -156.2%
Net Cash from Investing -103 -80 -28.7%
Financing Activities
Proceeds From Repayments Of Short Term Debt -1,128 -244 -362.3%
Repayments Of Other Debt 0 -1 +100.0%
Proceeds From Other Debt 691 0 —
Payments Of Ordinary Dividends -523 -514 -1.8%
Share Repurchases -406 -455 +10.8%
Proceeds From Stock Options Exercised 18 27 -33.3%
Proceeds From Payments For Other Financing Activities -13 -92 +85.9%
Net Cash from Financing -1,361 -1,279 -6.4%
Supplemental
Income Taxes Paid 201 171 +17.5%
Interest Paid 35 35 0.0%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 20 -48 +141.7%
Net Change in Cash 9 -138 +106.5%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,288 1,096 +17.5%

Values in millions USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key